Partner
Norton Rose Fulbright US LLP
Steven Lofchie is a Partner based in New York. He advises financial institutions and corporate clients on the securities laws and the Commodity Exchange Act, with particular focus on the regulation of broker-dealers, swap dealers, investment funds and other market intermediaries. Steven's transactional practice focuses on securities credit and derivative transactions.
Recent Articles & Comments
Isn't this the type of matter in which the DOJ should be involved? Why is generating trading commissions from a dying and incapacitated person any different than sneaking into his hospital room and stealing his watch and wallet?
If one makes the very reasonable assumption that it is impossible to be perfectly assured for an indefinite period that data can be made absolutely safe from bad actors or from internal carelessness, it follows that there is tremendous risk in centralizing so much data in one place. Even assuming that having all this data will materially improve the ability of the regulators to monitor the markets and protect investors - as is no doubt the case - is that benefit really worth the risk? If…
Libra is an asset-backed coin (an "ABCoin"), not a stablecoin. It is neither fixed in value as against the local fiat currency (meaning the dollar in the United States) nor fixed in value against a determinate basket of currencies (as Libra reserves the right to change the relevant basket). This distinction, or the failure to make this distinction, is very important because genuine stablecoins can provide all of the benefits that the CRS study posits could be provided by Libra, but can do…
If the SEC is trying to improve the public willingness to invest in smaller companies, it should focus less on how the securities trade and more on the availability of information about these issuers; e.g., investment research. The outcome of the early 2000s enforcement actions over broker-dealers producing research reports tainted by conflicts of interest were that the regulators adopted rules that significantly raised the costs of producing research and simultaneously deprived firms of a…